CurvaFix, Inc.
United States
- Bellevue, Washington
- 17/07/2023
- Series C
- $39,000,000
CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.
- Industry Medical Equipment Manufacturing
- Website https://curvafix.com/
- LinkedIn https://www.linkedin.com/company/curvafix-llc/
Related People
Steve DimmerFounder
United States -
Bellevue, Washington
30 years building medical technology companies. Deep experience leading development and commercialization of novel, disruptive health care solutions spanning diagnostic & therapeutic medical devices and drug delivery. Built world class teams in areas of orthopedics, pulmonology, oncology, diagnostics, and general surgery. Raised over $80 million from angels, VCs, family offices, and strategics. Inventor on over 100 U.S patents.
Forage | $40,000,000 | (Jun 5, 2026)
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Terra AI | $20,000,000 | (Jun 5, 2026)
Town | $55,000,000 | (Jun 5, 2026)
Lassie | $35,000,000 | (Jun 5, 2026)
OFFROAD | $7,000,000 | (Jun 5, 2026)
Shifters | $10,200,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Scispot | $8,000,000 | (Jun 5, 2026)
Scotch | $20,000,000 | (Jun 5, 2026)